SCHEMBL7049542

SCHEMBL7049542

CC(C)(C)OC(=O)NCC(C(=O)NCC(O)(CCc1ccccc1)c1nc2ccccc2o1)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.40
ATM Q13315 2/20 0.40
NPSR1 Q6W5P4 7/20 0.39
HPGD P15428 6/20 0.39
HTT P42858 6/20 0.39
ALDH1A1 P00352 5/20 0.39
LMNA P02545 5/20 0.39
HSD17B10 Q99714 4/20 0.39
XBP1 P17861 3/20 0.39
PKM P14618 3/20 0.39
TSHR P16473 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
ALOX15 P16050 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SYK P43405 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6462741 0.89 FAAH (0.36) MAPTALDH1A1LMNATSHRKMT2A
SCHEMBL6467288 0.85 NPSR1 (0.38) MAPTNPSR1ALDH1A1LMNAHSD17B10
SCHEMBL6462894 0.82 MEN1 (0.38) MAPTHTTALDH1A1LMNAKMT2A
SCHEMBL7046906 0.82 MAPT (0.43) MAPTNPSR1HTTALDH1A1LMNA
SCHEMBL6063046 0.81 LMNA (0.36) HPGDHTTLMNAKMT2AMEN1
SCHEMBL6463256 0.79 CTSS (0.38) NPSR1LMNATSHRKMT2AMEN1
Hydrochloric Acid SCHEMBL6465937 0.77 FAAH (0.35) MAPTALDH1A1LMNATSHRKMT2A
SCHEMBL6061831 0.75 RAB9A (0.34) MAPTCTSSTP53RAB9A
SCHEMBL7049306 0.74 DAGLA (0.44) MAPTHPGDHTTALDH1A1LMNA
SCHEMBL7042185 0.74 ATM (0.39) MAPTATMNPSR1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2003-12-18 US disclosed
US-6576630-B1 Alkanoyl substituted benzooxazoles or naphthooxazoles AXYS PHARMACEUTICALS, INC. 2003-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors SERPINB1, CTRL, CTSZ MAPT 2414/4885ATM 3419/4885NPSR1 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.